Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001557638 | SCV001779433 | likely benign | not provided | 2020-06-10 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002506663 | SCV002801199 | likely benign | Micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome; Intellectual developmental disorder, autosomal dominant 63, with macrocephaly | 2022-05-09 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001557638 | SCV005259683 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Genome Diagnostics Laboratory, |
RCV001557638 | SCV001978438 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001557638 | SCV001980398 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV004551903 | SCV004725046 | likely benign | TRIO-related disorder | 2024-01-22 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |